Building our COVID-19 convalescent plasma stocks
Supporting clinical trials
We're continuing to build stocks to support the REMAP CAP and RECOVERY clinical trials.
In order to maximise our stocks we are collecting convalescent plasma from female donors who have tested negative for HLA and HNA antibodies, and from donors who have received convalescent plasma as part of their treatment.
Lucy Frith, Process Improvement Manager